Stay updated on CHF5993 pMDI vs Symbicort Turbuhaler in COPD Clinical Trial
Sign up to get notified when there's something new on the CHF5993 pMDI vs Symbicort Turbuhaler in COPD Clinical Trial page.

Latest updates to the CHF5993 pMDI vs Symbicort Turbuhaler in COPD Clinical Trial page
- Check4 days agoChange DetectedAn updated revision tag was added, replacing v3.5.4 with v3.5.5, indicating a new version of the study protocol and related documents. This change reflects an internal document revision rather than a modification to public-facing content or results.SummaryDifference0.0%

- Check11 days agoChange DetectedClinicalTrials.gov entry NCT03197818 for TRIVERSYTI now shows posted results, including final analyses of screened and randomized patients and multiple outcome measures (lung function, QoL, and health economics). The update also documents run-in procedures, remote visit adaptations due to COVID-19, and the extensive list of participating sites.SummaryDifference9%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4, indicating a newer version of the page publication. This change appears to affect metadata rather than substantive study content.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page revision label has been updated from v3.5.2 to v3.5.3, reflecting a site/version update rather than any change to the underlying study information.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check61 days agoChange DetectedNo additions or deletions were detected between the two screenshots; the page content remains unchanged.SummaryDifference0.0%

Stay in the know with updates to CHF5993 pMDI vs Symbicort Turbuhaler in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CHF5993 pMDI vs Symbicort Turbuhaler in COPD Clinical Trial page.